Tell me the stage of carcinoma if possible
I'll read both PDFs to extract the clinical information needed to determine the stage.
Reading File
Now let me extract text from both PDFs simultaneously.
Running Command
python3 -c " import pdfplumber files = [ '/home/daytona/workspace/attachments/2187da3c-8257-41ed-8142-4e00514f43eb/Breast Tru Cut Biopsy with ER, PR, Herce.pdf', '/home/daytona/workspace/attachments/2187da3c-8257-41ed-8142-4e00514f43eb/3D Mammography both Breast.pdf' ] for f in files: print('='*60) print('FILE:', f) print('='*60) with pdfplumber.open(f) as pdf: for i, page in enumerate(pdf.pages): text = page.extract_text() if text: print(f'--- Page {i+1} ---') print(text) "
I have all the data needed. Here is a full analysis:
Mrs. Prem Narula - Breast Carcinoma Summary
Diagnosis
Right Breast: Invasive Ductal Carcinoma (IDC), Grade 2
TNM Staging (AJCC 8th Edition)
| Parameter | Finding | TNM |
|---|---|---|
| Primary Tumor | 3 x 2 cm mass, right breast retroareolar, with skin thickening/retraction | T2 (>2 cm, ≤5 cm) |
| Regional Nodes | No significant axillary lymphadenopathy on mammogram | cN0 (clinically node-negative) |
| Distant Metastasis | No distant metastasis reported | M0 |
Note on the axillary tail mass: A separate 12 x 12 mm BIRADS 4 mass is seen in the right axillary tail region. This is radiologically suspicious but was classified M4 (not M5). It has not been biopsied yet. If this represents an intramammary or axillary node with metastasis, the N stage would upgrade. This needs ultrasound-guided biopsy for confirmation.
Provisional Clinical Stage
Stage IIA (cT2 N0 M0)
(If the axillary tail lesion proves to be a malignant node on biopsy, stage would upgrade to Stage IIB: T2 N1 M0)
Biomarker Profile (Receptor Status)
| Marker | Result | Significance |
|---|---|---|
| ER | Positive (>95%, strong - Allred 8/8) | Hormone receptor positive |
| PR | Positive (85-90%, weak-moderate - Allred 7/8) | Hormone receptor positive |
| HER2 | Negative (IHC 1+) | HER2-negative |
| Ki-67 | 15-18% | Intermediate proliferation |
Molecular Subtype: Luminal B (HR+/HER2-) with intermediate Ki-67
This is the most favorable subtype - it typically responds well to hormonal therapy (e.g., letrozole/tamoxifen) ± chemotherapy.
Key Points
- Skin thickening and retraction are present but this alone does not automatically make it T4 (T4b requires clinical skin involvement such as ulceration, satellite nodules, or edema/peau d'orange - skin retraction on imaging is still classified as T2/T3 based on size unless there is true dermal invasion confirmed).
- No lymphovascular invasion on biopsy - a favorable prognostic sign.
- TILs 5-10% - low, not a strong immunological response.
- Grade 2 (moderately differentiated) - intermediate prognosis.
- Complete staging will require axillary ultrasound + biopsy of the axillary tail lesion, and systemic staging (CT chest/abdomen/pelvis or PET-CT) to fully confirm M0 status, especially given the patient's age (82 years).
Bottom line: Based on available data, this is provisionally Stage IIA (T2 N0 M0), HR+/HER2-, Grade 2 Invasive Ductal Carcinoma. Final staging requires clarification of the axillary tail lesion and systemic imaging.
This is a shared conversation. Sign in to Orris to start your own chat.